---
schema_version: "secwatch.filing_event.v1"
accession: "0001161697-26-000051"
form_type: "8-K"
ticker: "KRMD"
cik: "0000704440"
company_name: "KORU Medical Systems, Inc."
filed_at: "2026-03-12T23:59:59+00:00"
generated_at: "2026-05-15T14:27:37.615742+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# KORU Medical reports 22% FY2025 revenue growth; positive adjusted EBITDA; initiates FY2026 guidance

## Summary
- Q4 2025 net revenue $10.9M (+23% YoY); FY2025 net revenue $41.1M (+22% YoY).
- International Core revenue grew 80% in FY2025; Domestic Core grew 11%.
- FY2025 net loss narrowed 57% to $2.6M ($0.06 loss per share); positive adjusted EBITDA of $0.6M.
- Cash and cash equivalents $8.9M at Dec 31, 2025; used only $0.7M cash in FY2025.
- FY2026 guidance: net revenue $47.5–$50.0M (15–22% growth); positive adjusted EBITDA and positive cash flow.

## SEC filing metadata
- accession: 0001161697-26-000051
- form_type: 8-K
- ticker: KRMD
- cik: 0000704440
- company_name: KORU Medical Systems, Inc.
- filed_at: 2026-03-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/704440/000116169726000051/0001161697-26-000051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/704440/000116169726000051/form_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001161697-26-000051
- JSON: https://secwatch.observer/filing/0001161697-26-000051.json
- Plain text: https://secwatch.observer/filing/0001161697-26-000051.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.